1,520
Views
38
CrossRef citations to date
0
Altmetric
Research Article

Development and in vitro/in vivo evaluation of Zn-pectinate microparticles reinforced with chitosan for the colonic delivery of progesterone

, , &
Pages 2541-2554 | Received 31 Jan 2015, Accepted 09 Mar 2015, Published online: 08 Apr 2015

References

  • Andréen L, Spigset O, Andersson A, et al. (2006). Pharmacokinetics of progesterone and its metabolites allopregnanolone and pregnanolone after oral administration of low-dose progesterone. Maturitas 54:238–44
  • Araujo V, Gamboa A, Caro N, et al. (2013). Release of prednisolone and inulin from a new calcium-alginate chitosan-coated matrix system for colonic delivery. J Pharm Sci 102:2748–59
  • Auriemma G, Mencherini T, Russo P, et al. (2013). Prilling for the development of multi-particulate colon drug delivery systems: pectin vs. pectin–alginate beads. Carbohydr Polym 92:367–73
  • Bai XY, Yan Y, Wang L, et al. (2015). Novel pH-sensitive hydrogels for 5-aminosalicylic acid colon targeting delivery: in vivo study with ulcerative colitis targeting therapy in mice. Drug Deliv. Early Online: 1--7. doi:10.3109/10717544.2014.996924
  • Bajpai SK, Sharma S. (2004). Investigation of swelling/degradation behaviour of alginate beads crosslinked with Ca2+ and Ba2+ ions. React Funct Polym 59:129–40
  • Baker R, Lonsdale H. (1974). Controlled release: mechanisms and rates. In: Tanquary AC, Lacey RE. eds. Controlled release of biologically active agents. New York: Plenum Press, 15–71
  • Basak P, Adhikari B. (2009). Poly (vinyl alcohol) hydrogels for pH dependent colon targeted drug delivery. J Mater Sci Mater Med 20:S137–46
  • Basit AW. (2005). Advances in colonic drug delivery. Drugs 65:1991–2007
  • Berggren J, Alderborn G. (2001). Effect of drying rate on porosity and tabletting behaviour of cellulose pellets. Int J Pharm 227:81–96
  • Bigucci F, Luppi B, Cerchiara T, et al. (2008). Chitosan/pectin polyelectrolyte complexes: selection of suitable preparative conditions for colon-specific delivery of vancomycin. Eur J Pharm Sci 35:435–41
  • Bode H, Brendel E, Ahr G, et al. (1996). Investigation of nifedipine absorption in different regions of the human gastrointestinal (GI) tract after simultaneous administration of 13C-and 12C-nifedipine. Eur J Clin Pharmacol 50:195–201
  • Borges O, Borchard G, Verhoef JC, et al. (2005). Preparation of coated nanoparticles for a new mucosal vaccine delivery system. Int J Pharm 299:155–66
  • Bourgeois S, Gernet M, Pradeau D, et al. (2006). Evaluation of critical formulation parameters influencing the bioactivity of β-lactamases entrapped in pectin beads. Int J Pharm 324:2–9
  • Carbinatto FM, de Castro AD, Evangelista RC, Cury BSF. (2014). Insights into the swelling process and drug release mechanisms from cross-linked pectin/high amylose starch matrices. Asian J Pharm Sci 9:27–34
  • Chawla V, Tiwary AK, Gupta S. (2000). Characterization of polyvinyl alcohol microspheres of diclofenac sodium: application of statistical design. Drug Dev Ind Pharm 26:675–80
  • Chen H, Fan M. (2007). Chitosan/carboxymethyl cellulose polyelectrolyte complex scaffolds for pulp cells regeneration. J Bioact Compat Polym 22:475–91
  • Chourasia MK, Jain SK. (2004). Polysaccharides for colon targeted drug delivery. Drug Deliv 11:129–48
  • Das S, Chaudhury A, Ng K-Y. (2011). Preparation and evaluation of zinc–pectin–chitosan composite particles for drug delivery to the colon: role of chitosan in modifying in vitro and in vivo drug release. Int J Pharm 406:11–20
  • Das S, Ng KY. (2010a). Impact of glutaraldehyde on in vivo colon-specific release of resveratrol from biodegradable pectin-based formulation. J Pharm Sci 99:4903–16
  • Das S, Ng KY. (2010b). Resveratrol-loaded calcium-pectinate beads: effects of formulation parameters on drug release and bead characteristics. J Pharm Sci 99:840–60
  • Del Curto MD, Maroni A, Foppoli A, et al. (2009). Preparation and evaluation of an oral delivery system for time-dependent colon release of insulin and selected protease inhibitor and absorption enhancer compounds. J Pharm Sci 98:4661–9
  • Dollery C. (1999). Therapeutic drugs, 2nd ed. London, UK: Churchill Livingstone
  • El-Gibaly I. (2002). Oral delayed-release system based on Zn-pectinate gel (ZPG) microparticles as an alternative carrier to calcium pectinate beads for colonic drug delivery. Int J Pharm 232:199–211
  • Eun SS, Yang S, Choe S. (2004). Mechanism of the formation of stable microspheres by precipitation copolymerization of styrene and divinylbenzene. J Polym Sci Part A: Polym Chem 42:3967–74
  • George M, Abraham TE. (2006). Polyionic hydrocolloids for the intestinal delivery of protein drugs: Alginate and chitosan—a review. J Control Release 114:1–14
  • Gibaldi M. (1991). Biopharmaceutics and clinical pharmaceutics, 4th ed. Philadelphia (PA): Lea & Febiger
  • Hagesaether E, Bye R, Sande SA. (2008). Ex vivo mucoadhesion of different zinc-pectinate hydrogel beads. Int J Pharm 347:9–15
  • Higuchi T. (1963). Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 52:1145–9
  • Hiorth M, Versland T, Heikkilä J, et al. (2006). Immersion coating of pellets with calcium pectinate and chitosan. Int J Pharm 308:25–32
  • Ishibashi T, Ikegami K, Kubo H, et al. (1999). Evaluation of colonic absorbability of drugs in dogs using a novel colon-targeted delivery capsule (CTDC). J Control Release 59:361–76
  • Jeong Y-I, Ohno T, Hu Z, et al. (2001). Evaluation of an intestinal pressure-controlled colon delivery capsules prepared by a dipping method. J Control Release 71:175–82
  • Jin L, Ding Y, Feng M, Cao Q. (2014). Preparation oral levofloxacin colon-specific microspheres delivery: in vitro and in vivo studies. Drug Deliv 17:1–7
  • Jose S, Prema MT, Chacko AJ, et al. (2011). Colon specific chitosan microspheres for chronotherapy of chronic stable angina. Colloids Surf B Biointerfaces 83:277–83
  • Klein S, Stein J, Dressman J. (2005). Site-specific delivery of anti-inflammatory drugs in the gastrointestinal tract: an in-vitro release model. J Pharm Pharmacol 57:709–19
  • Krishnaiah YSR, Satyanarayana S, Prasad RYV, Rao NS. (1998). Gamma scintigraphic studies on guar gum matrix tablets for colonic drug delivery in healthy human volunteers. J Control Release 55:245–52
  • Kshirsagar SJ, Bhalekar MR, Shewale NS, et al. (2011). Development of enzyme-controlled colonic drug delivery using amylose and hydroxypropyl methylcellulose: optimization by factorial design. Drug Deliv 18:385–93
  • Langer R, Peppas N. (1981). Present and future applications of biomaterials in controlled drug delivery systems. Biomaterials 2:201–14
  • Liu Q, Wang X-Y, Zhang H. (2007). Solvent effects on infrared spectra of progesterone in CHCl3/cyclo-C6H12 binary solvent systems. Spectrochim Acta A Mol Biomol Spectrosc 66:202–7
  • Lootens D, Capel F, Durand D, et al. (2003). Influence of pH, Ca concentration, temperature and amidation on the gelation of low methoxyl pectin. Food Hydrocoll 17:237–44
  • Maestrelli F, Cirri M, Corti G, et al. (2008a). Development of enteric-coated calcium pectinate microspheres intended for colonic drug delivery. Eur J Pharm Biopharm 69:508–18
  • Maestrelli F, Zerrouk N, Cirri M, et al. (2008b). Microspheres for colonic delivery of ketoprofen-hydroxypropyl-β-cyclodextrin complex. Eur J Pharm Sci 34:1–11
  • Marudova M, Lang S, Brownsey GJ, Ring SG. (2005). Pectin–chitosan multilayer formation. Carbohydr Res 340:2144–9
  • Marudova M, MacDougall AJ, Ring SG. (2004). Pectin–chitosan interactions and gel formation. Carbohydr Res 339:1933–9
  • McLeod AD, Friend DR, Tozer TN. (1994). Glucocorticoid-dextran conjugates as potential prodrugs for colon-specific delivery: hydrolysis in rat gastrointestinal tract contents. J Pharm Sci 83:1284–8
  • Memişoğlu E, Bochot A, Şen M, et al. (2003). Non-surfactant nanospheres of progesterone inclusion complexes with amphiphilic β-cyclodextrins. Int J Pharm 251:143–53
  • Mennini N, Furlanetto S, Cirri M, Mura P. (2012). Quality by design approach for developing chitosan-Ca-alginate microspheres for colon delivery of celecoxib-hydroxypropyl-β-cyclodextrin-PVP complex. Eur J Pharm Biopharm 80:67–75
  • Mennini N, Furlanetto S, Maestrelli F, et al. (2008). Response surface methodology in the optimization of chitosan–Ca pectinate bead formulations. Eur J Pharm Sci 35:318–25
  • Munjeri O, Collett JH, Fell JT. (1997). Hydrogel beads based on amidated pectins for colon-specific drug delivery: the role of chitosan in modifying drug release. J Control Release 46:273–8
  • Mura P, Maestrelli F, Cirri M, et al. (2003). Development of enteric-coated pectin-based matrix tablets for colonic delivery of theophylline. J Drug Target 11:365–71
  • Muraoka M, Hu Z, Shimokawa T, et al. (1998). Evaluation of intestinal pressure-controlled colon delivery capsule containing caffeine as a model drug in human volunteers. J Control Release 52:119–29
  • Nappinnai M, Sivaneswari S, Swain S, et al. (2013). Formulation optimization and characterization of gastroretentive cefpodoxime proxetil mucoadhesive microspheres using 32 factorial design. J Pharm Res 7:304–9
  • Oliveira GF, Ferrari PC, Carvalho LQ, Evangelista RC. (2010). Chitosan–pectin multiparticulate systems associated with enteric polymers for colonic drug delivery. Carbohydr Polym 82:1004–9
  • Qureshi MJ, Ali J, Baboota S, et al. (2014). Pharmacokinetic study of a capsule-based chronomodulated drug delivery system of salbutamol sulphate in rabbits. Trop J Pharm Res 13:17–22
  • Rai G, Yadav AK, Jain NK, Agrawal GP. (2014). Eudragit-coated dextran microspheres of 5-fluorouracil for site-specific delivery to colon. Drug Deliv 20:1–10
  • Ramasamy T, Ruttala HB, Shanmugam S, Umadevi SK. (2013). Eudragit-coated aceclofenac-loaded pectin microspheres in chronopharmacological treatment of rheumatoid arthritis. Drug Deliv 20:65–77
  • Ribeiro LNM, Alcântara ACS, Darder M, et al. (2014). Pectin-coated chitosan–LDH bionanocomposite beads as potential systems for colon-targeted drug delivery. Int J Pharm 463:1–9
  • Riley S, Turnberg L. (1990). Sulphasalazine and the aminosalicylates in the treatment of inflammatory bowel disease. QJM 75:551–62
  • Risbud MV, Hardikar AA, Bhat SV, Bhonde RR. (2000). pH-sensitive freeze-dried chitosan–polyvinyl pyrrolidone hydrogels as controlled release system for antibiotic delivery. J Control Release 68:23–30
  • Ritger PL, Peppas NA. (1987). A simple equation for description of solute release II. Fickian and anomalous release from swellable devices. J Control Release 5:37–42
  • Rubinstein A. (1995). Approaches and opportunities in colon-specific drug delivery. Crit Rev Ther Drug Carrier Syst 12:101–49
  • Rubinstein A. (2005). Colonic drug delivery. Drug Discov Today Technol 2:33–7
  • Sareen R, Jain N, Rajkumari A, Dhar KL. (2014). pH triggered delivery of curcumin from Eudragit-coated chitosan microspheres for inflammatory bowel disease: characterization and pharmacodynamic evaluation. Drug Deliv. Early Online: 1--8. doi:10.3109/10717544.2014.903534
  • Semdé R, Amighi K, Devleeschouwer MJ, Moës AJ. (2000). Effect of pectinolytic enzymes on the theophylline release from pellets coated with water insoluble polymers containing pectin HM or calcium pectinate. Int J Pharm 197:169–79
  • Sharma S, Kaur J, Sharma G, et al. (2013). Preparation and characterization of pH-responsive guar gum microspheres. Int J Biol Macromol 62:636–41
  • Simonoska Crcarevska M, Glavas Dodov M, Goracinova K. (2008). Chitosan coated Ca–alginate microparticles loaded with budesonide for delivery to the inflamed colonic mucosa. Eur J Pharm Biopharm 68:565–78
  • Sinha VR, Kumria R. (2003). Microbially triggered drug delivery to the colon. Eur J Pharm Sci 18:3–18
  • Sinha VR, Singla AK, Wadhawan S, et al. (2004). Chitosan microspheres as a potential carrier for drugs. Int J Pharm 274:1–33
  • Sood A, Panchagnula R. (1998). Drug release evaluation of diltiazem CR preparations. Int J Pharm 175:95–107
  • Steed K, Hooper G, Monti N, et al. (1997). The use of pharmacoscintigraphy to focus the development strategy for a novel 5-ASA colon targeting system (“TIME CLOCK®” system). J Control Release 49:115–22
  • Sweetman SC. (2009). Martindale: The complete drug reference, 36th ed. London: Pharmaceutical press
  • Thirawong N, Nunthanid J, Puttipipatkhachorn S, Sriamornsak P. (2007). Mucoadhesive properties of various pectins on gastrointestinal mucosa: an in vitro evaluation using texture analyzer. Eur J Pharm Biopharm 67:132–40
  • Varshosaz J, Dehkordi JA, Golafshan S. (2006). Colon-specific delivery of mesalazine chitosan microspheres. J Microencapsul 23:329–39
  • Vervoort L, Rombaut P, Van den Mooter G, et al. (1998). Inulin hydrogels. II. In vitro degradation study. Int J Pharm 172:137–45
  • Wan S, Sun Y, Sun L, Tan F. (2012). Chitosan microparticles for oral bioavailability improvement of the hydrophobic drug curcumin. Pharmazie 67:525–8
  • Wei X, Lu Y, Qi J, et al. (2014). An in situ crosslinked compression coat comprised of pectin and calcium chloride for colon-specific delivery of indomethacin. Drug Deliv. Early Online: 1--8. doi:10.3109/10717544.2013.879965
  • Wittaya-areekul S, Kruenate J, Prahsarn C. (2006). Preparation and in vitro evaluation of mucoadhesive properties of alginate/chitosan microparticles containing prednisolone. Int J Pharm 312:113–18
  • Wu Z, Zhang C, Yang C, et al. (2000). Simultaneous quantitative determination of norgestrel and progesterone in human serum by high-performance liquid chromatography-tandem mass spectrometry with atmospheric pressure chemical ionization. Analyst 125:2201–5
  • Xi MM, Zhang SQ, Wang XY, et al. (2005). Study on the characteristics of pectin–ketoprofen for colon targeting in rats. Int J Pharm 298:91–7
  • Yang L, Chu JS, Fix JA. (2002). Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation. Int J Pharm 235:1–15
  • Yu C-Y, Yin B-C, Zhang W, et al. (2009). Composite microparticle drug delivery systems based on chitosan, alginate and pectin with improved pH-sensitive drug release property. Colloids Surf B Biointerfaces 68:245–9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.